Oseltamivir Phosphate Capsule
Product Images NDC 68788-8831

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 68788-8831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 01)

FDA Label Image

A Close-up Of A Labelai-generated Content May Be Incorrect. (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 04)

A Close-up Of A Labelai-generated Content May Be Incorrect. (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 04)
This is a description of Oseltamivir Phosphate Capsules USP 75mg, a generic version of Tamiflu. Each capsule contains oseltamivir phosphate equivalent to 75mg of oseltamivir. This medication is manufactured by Lupin Limited and should be stored at 25 degrees Celsius. The capsules are gray and light yellow, imprinted with LU 75mg. It includes directions for use in English and Spanish. Additionally, there are details about packaging size, expiration date, and warnings including information on federal law regarding drug use.*
FDA Label Image

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 241 1)

FDA Label Image

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 296 1)

FDA Label Image

Image (2d3e96ad 5331 4429 9c1f 8eaf542c8bcc 299 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.